Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Brain Neoplasms 19Neoplasm Metastasis 13Lung Neoplasms 13Pancreatic Neoplasms 11Melanoma 10Carcinoma, Renal Cell 9Carcinoma, Hepatocellular 9Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Neoplasms 6Glioblastoma 6Breast Neoplasms 6Liver Neoplasms 5Head and Neck Neoplasms 4Glioma 3Colorectal Neoplasms 3Uveal Melanoma 2Sarcoma 2Mesothelioma 2Gliosarcoma 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor 1Spinal Cord Compression 1Secondary Malignant Neoplasm of Liver 1Sarcoma, Ewing 1

Interventions

phenoxodiol 1Suppositories 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Metastatic Castrate- Resistant Prostate Cancer × Radiosurgery × Clear all
NCT03041285 2022-05-11

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Royal North Shore Hospital

Phase 1 Terminated
1 enrolled
Genitourinary

Metastatic Castrate- Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡